Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL7880569 | 0.85 | ALDH1A1 (0.38) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL1499263 | 0.84 | — | — | |
| Ether SCHEMBL9154773 | 0.82 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2TDP1PDK1 | |
| Ether SCHEMBL539347 | 0.81 | SMN1; SMN2 (0.58) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL3620829 | 0.80 | — | — | |
| Ether SCHEMBL501965 | 0.79 | ALDH1A1 (0.65) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| Ether SCHEMBL498277 | 0.79 | SMN1; SMN2 (0.40) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| Ether SCHEMBL21240724 | 0.79 | SMN1; SMN2 (0.50) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| Ether SCHEMBL5400744 | 0.79 | SMN1; SMN2 (0.40) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL3625996 | 0.79 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080045667-A1 | Process for preparing polyoxyalkylene glycol ethers using block polymers as demulsifiers | CLARIANT INTERNATIONAL LTD. | 2008-02-21 | — | — | US | claimed |
| US-20070149793-A1 | Heterogeneous ruthenium catalyst, nucleus-hydrogenated diglycidyl ether of bisphenols a and f, and method for the production thereof | BASF AKTIENGESELLSCHAFT PATENTS, TRADEMARKS AND LICENSES (DE) | 2007-06-28 | — | — | US | claimed |
| US-20240059838-A1 | ALKOXYLATED POLYMERIC N-(HYDROXYALKYL)AMINE AS WETTING AGENTS AND AS A COMPONENT OF DEFOAMER COMPOSITIONS | BASF SE (DE) | 2024-02-22 | — | — | US | disclosed |
| EP-4263673-A1 | ALKOXYLATED POLYMERIC N-(HYDROXYALKYL)AMINE AS WETTING AGENTS AND AS A COMPONENT OF DEFOAMER COMPOSITIONS | BASF SE (DE) | 2023-10-25 | — | — | EP | disclosed |
| WO-2022129368-A1 | ALKOXYLATED POLYMERIC N-(HYDROXYALKYL)AMINE AS WETTING AGENTS AND AS A COMPONENT OF DEFOAMER COMPOSITIONS | BASF SE (DE) | 2022-06-23 | — | — | WO | disclosed |
| WO-2018184151-A1 | Light cure epoxy composition | HENKEL AG & CO. KGAA (DE) | 2018-10-11 | — | — | WO | disclosed |
| EP-2209836-B1 | ALKOXYLATED POLYALKANOLAMINES | BASF SE (DE) | 2016-02-24 | — | — | EP | disclosed |
| CN-103111270-B | Adsorbing material of hepatitis B antigen protein and preparation method of material | WANG YEFU | 2015-06-10 | — | — | CN | disclosed |
| CN-103111270-A | Adsorbing material of hepatitis B antigen protein and preparation method thereof | WUHAN ZHENFU MEDICAL SCIENCE & TECHNOLOGY DEV CO LTD | 2013-05-22 | — | — | CN | disclosed |
| US-8129326-B2 | Alkoxylated polyalkanolamines | BASF SE (DE) | 2012-03-06 | — | — | US | disclosed |
| US-20100234631-A1 | ALKOXYLATED POLYALKANOLAMINES | BASF SE (DE) | 2010-09-16 | — | — | US | disclosed |
| EP-2209836-A1 | ALKOXYLATED POLYALKANOLAMINES | BASF SE (DE) | 2010-07-28 | — | — | EP | disclosed |
| WO-2009060060-A1 | ALKOXYLATED POLYALKANOLAMINES | BASF SE (DE) | 2009-05-14 | — | — | WO | disclosed |
| CN-1687168-A | Method for preparing grouting material of modified polyacrylamide | GUANGZHOU INST CHEMISTRY CAS (CN) | 2005-10-26 | — | — | CN | disclosed |
| US-5093392-A | Paint for food and beverage containers | THE GLIDDEN COMPANY (US) | 1992-03-03 | — | — | US | disclosed |
| US-5051470-A | Self-curing graft polymer formed by copolymerization of ethylenically unsaturated monomers in the presence of the epoxy resin and dispersion by adding an amine | THE GLIDDEN COMPANY (US) | 1991-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070149793-A1 | Heterogeneous ruthenium catalyst, nucleus-hydrogenated diglycidyl ether of bisphenols a and f, and method for the production thereof | HNRNPL, HNRNPH3, HNRNPF | ALDH1A1 4287/4885SMN1; SMN2 3901/4885TDP1 3580/4885 |
| US-20100234631-A1 | ALKOXYLATED POLYALKANOLAMINES | PHOSPHO1, ALK, PARN | ALDH1A1 3742/4885SMN1; SMN2 4604/4885TDP1 3019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.